Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|6|666-677

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.6, 2016-05, pp. : 666-677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Targeting of TRPV1 by Resiniferatoxin, from Preclinical Studies to Clinical Trials

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 17, 2011-09 ,pp. : 2159-2170

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Killer T Cells as Targets for Therapeutic Intervention in Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 9, Iss. 3, 2003-01 ,pp. : 201-220

Bentham Science Publishers

Access to resources Recommend Favorite

Review: Therapeutic Targeting of HMGB1 in Stroke

By  

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 785-790

Bentham Science Publishers

Access to resources Recommend Favorite

Modern Therapeutic Strategies for Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4508-4512

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Monitoring of Immunotherapies in Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4550-4555

Bentham Science Publishers

Access to resources Recommend Favorite